CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EZZ Life Science Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EZZ Life Science Holdings Ltd
104 Derby Street
Phone: +61 280021376p:+61 280021376 SYDNEY, NSW  2128  Australia Ticker: EZZEZZ

Business Summary
EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Glenn W.Cross 12/1/2021 12/1/2021
Chief Financial Officer Brent J.Goldman 7/31/2020 7/31/2020
Chief Operating Officer, Executive Director QizhouQin 9/1/2019 9/1/2019
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 42,705,000 (As of 12/31/2023)
Shareholders: 840
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024